Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
Anaphylaxis quizlet
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: Anaphylaxis quizlet
Title of article is A Study of Safety and Efficacy of CNTO 148 in Patients with Severe Persistent Asthma (ClinicalTrials.gov, 2013). The official title is A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel-group, Dose-ranging Study Evaluating the Efficacy and Safety of CNTO 148 Administered Subcutaneously in Symptomatic Subjects with Severe Persistent Asthma.
a. Purpose of the study
The purpose of this study is to evaluate the effectiveness and safety of CNTO 148 (golimumab) in patients with severe persistent asthma. This is a multicenter, randomized (the study medication is assigned by chance), double-blind (neither physician nor patient knows the treatment that the patient receives), placebo-controlled (an inactive
…show more content…
Patient inclusion criteria
• Physician diagnosis of asthma for greater than or equal to 3 years and a diagnosis of severe persistent asthma forgreater than or equal to 1 year to screening
• Continuous treatment with high dose Inhaled corticosteroids (ICS) and long acting beta-agonist for at least 3 months prior to screening
• Have evidence of at least 1 of the following in the 5 years prior to screening or during screening, reversible airway obstruction greater than or equal to 12 percentage change in forced expiratory volume in 1 second (FEV1) postbronchodilator; Diurnal variation in peak expiratory flow rate (PEFR) greater than or equal to 30 percentage change) and airway hyperresponsiveness
• Estimated frequency of symptoms on more than one-third of days for at least 3 months prior to screening (e.g., wheezing, breathlessness, chest tightness, cough, nocturnal awakening) despite treatment with high dose ICS and long-acting ß2-agonist (LABA) with or without continuous oral
…show more content…
Disadvantages is anaphylaxis. “Subcutaneous allergen immunotherapy, the oldest biologic agent in current use, has the highest of frequency of the most serious and life-threatening reaction, anaphylaxis. It is also one of the only disease modifying interventions for allergic rhinitis and asthma” (Cox, 2009).
f. Your opinion on the research value of this study to advance patient care.
Golimumab was used on 309 patients with asthma. Monthly SC injections of either placebo or golimumab at 50, 100, or 200 mg doses were administered through week 52. Efficacy was assessed from the change from baseline in the prebronchodilator percent-predicted forced expiratory volume 1 (FEV1) and the number of severe exacerbations at week 24. However, no significant changes were observed in these measures, and the agent was found to have an unfavorable risk-benefit profile in this patient population (Mazumdar & Greenwald,
Aims: To implement a multi-pronged strategy that (1) educates parents, students, and school staff about asthma and its management, (2) establishes comprehensive asthma screening programs, (3) develops affordable and long-term management strategies for students with asthma, and (4) increases the rigor of school inspections with regards to air quality and other common asthma triggers.
Asthma is a chronic inflammatory disease of the airways. It is a reversible airway obstruction, occurring 8 to 10% of the population worldwide. According to a study in 2005, asthma affects over 15 million Americans, with more than 2 million annual emergency room visits. Asthma patients have a hyper-responsiveness in their airways and generally and increase in their airway smooth muscle cell mass. This hyperplasia is due to the normal response to the injury and repair to the airway caused by exacerbations. The main choice of therapy for asthma patients is β2- adrenergic agonists. Racemic albuterol has been the drug of choice for a short acting bronchodilator for a long time, but since the development of levalbuterol, there is the question of which drug is a better choice for therapy. Efficacy and cost of treatment must both be taken into consideration in each study of these therapies to determine which is best for the treatment of asthma.
In the article "The Effect of Theophylline and ß2 agonists on Airway Reactivity" it says that more airway responsiveness occurs in asthma, chronic bronchitis, cystic fibrosis, and other diseases. Theophylline and ß2 agonists are used commonly for maintenance therapy for symptoms associated with the increased responsiveness. Both can reduce airway responsiveness to a variety of chemical irritants.. (Ahrens 15S)
Concerning his ongoing symptoms, it is likely that he has some mild asthma in association with low-grade rhinosinusitis and intermittent reflux. I have advised him to continue with Nexium, but he will commence Alvesco 160mvg daily and intranasal saline and steroid sprays.
Oxygen, inhaled bronchodilators, inhaled steroids, combination inhalers, oral steroids, phosphodiesterase-4 inhibitors and theophylline are effective medications for COPD (Mayo Clinic, 2016). “Patients with COPD have persistent high levels of CO2, their respiratory centers no longer respond to increased levels of CO2 by stimulating breathing. Therefore, COPD patients with more severe hypoxemia are at higher risk of CO2 retention from uncontrolled CO2 administration” (Van Houten, p. 13). For nurses, “It is important to administer the lowest amount of O2 necessary to patients” (Van Houten, p. 13). Some COPD medicines are used with inhaler and nebulizer devices. It is important to teach patients how to use these devices correctly. (Potter & Perry,
Carone M, D. C. ( 2007). Clinical Challenges In COPD[e-book]. (Oxford: Clinical Pub) Retrieved March 24, 2014, from (EBSCOhost).
The following information regards to the pharmaceutical medication albuterol. This medication is one of the most prescribed treatments for asthma symptoms in modern western medicine. Albuterol may be known as: Aerolin, Asmaven, Asthalin, Buventol, Broncovaleas, ProAir, Proventil, Salbutamol, Sultanol, Ventolin, and others.1 Knowing this, the contents that follow apply to each of the names above, and they will all be referred to as albuterol. The background of the medication, its chemistry, pharmacology, toxicology, and therapeutic application are compiled together from multiple reliable resources for the purpose of acquiring a brief informational document on the main aspects of albuterol in society.
Chronic obstructive pulmonary disease (COPD) is preventable disease that has a detrimental effects on both the airway and lung parenchyma (Nazir & Erbland, 2009). COPD categorises emphysema and chronic bronchitis, both of which are characterised by a reduced maximum expiratory flow and slow but forced emptying of the lungs (Jeffery 1998). The disease has the one of the highest number of fatalities in the developed world due to the ever increasing amount of tobacco smokers and is associated with significant morbidity and mortality (Marx, Hockberger & Walls, 2014). Signs and symptoms that indicate the presence of the disease include a productive cough, wheezing, dyspnoea and predisposing risk factors (Edelman et al., 1992). The diagnosis of COPD is predominantly based on the results of a lung function assessment (Larsson, 2007). Chronic bronchitis is differentiated from emphysema by it's presentation of a productive cough present for a minimum of three months in two consecutive years that cannot be attributed to other pulmonary or cardiac causes (Marx, Hockberger & Walls, 2014) (Viegi et al., 2007). Whereas emphysema is defined pathologically as as the irreversible destruction without obvious fibrosis of the lung alveoli (Marx, Hockberger & Walls, 2014) (Veigi et al., 2007).It is common for emphysema and chronic bronchitis to be diagnosed concurrently owing to the similarities between the diseases (Marx, Hockberger & Walls, 2014).
Chronic bronchitis is a disorder that causes inflammation to the airway, mainly the bronchial tubules. It produces a chronic cough that lasts three consecutive months for more than two successive years (Vijayan,2013). Chronic Bronchitis is a member of the COPD family and is prominently seen in cigarette smokers. Other factors such as air pollutants, Asbestos, and working in coal mines contributes to inflammation. Once the irritant comes in contact with the mucosa of the bronchi it alters the composition causing hyperplasia of the glands and producing excessive sputum (Viayan,2013). Goblet cells also enlarge to contribute to the excessive secretion of sputum. This effects the cilia that carry out the mechanism of trapping foreign bodies to allow it to be expelled in the sputum, which are now damaged by the irritant making it impossible for the person to clear their airway. Since the mechanism of airway clearance is ineffective, the secretion builds up a thickened wall of the bronchioles causing constriction and increasing the work of breathing. The excessive build up of mucous could set up pneumonia. The alveoli are also damaged enabling the macrophages to eliminate bacteria putting the patient at risk for acquiring an infection.
It is used as a bronchodilator in the treatment of asthma. It is also frequently administered in asthma inhalers as the primary active drug of the inhaler. The use of Clenbuterol as a medication for asthma is primarily a European medical practice while in North America, Clenbuterol’s sister compound “Albuterol”, is utilized instead. The activation of beta-2 receptors in the cell-lining of the bronchial tubes initiates the opening and expansion of the airways (bronchial dilation) in the nose, throat and lungs. Many sympathomimetic stimulants exert this effect however Clenbuterol and Albuterol are better effective in particular for this purpose. Clenbuterol is also used in the treatment of other medical conditions, such as cardiovascular shock, heart arrhythmias, hypertension, allergic reactions and swelling, migraine headaches, anaphylactic shock and histamine
CB is a 57-year-old male presents to your clinic for cough for past two months. States he has been having some shortness of breath when going up stairs. Denies any fevers or congestion, denies any chest pain or recent travel outside US. Patient states he does smoke ½ to 1 pack per day for the past 30 years. Patient does have history of HPTN and Hyperlipidemia which are controlled with medication. VS 130/78; rr 18; pulse ox 96%, hr 88.
Asthma is a disease that affects the breathing passages of the lungs (bronchioles). People who have asthma always have difficulty breathing. In the United States alone, over twenty-five million Americans are diagnosed with asthma. According to the Centers for Disease Control and Prevention (CDC), asthma is known to be the third most common disease as well as a leading cause to hospitalization in America. In 2008, one in two people were reported to have asthma attacks which is roughly about twelve million asthma attacks a year. In 2007, the United States spent more than fifty-six million dollars on medical costs, lost school and work days, and early deaths from asthma. Asthma is not visible to the human eye, so it is difficult in an emergency situation for the lay responder to tell whether the victim is having trouble breathing or having an asthma attack. Unlike people who are diabetic and have to wear medical ID bracelets, people with asthma are not required to wear them, but it should be recommended to help the lay responder, the doctors and the paramedics identify the situation they are dealing with at hand. For hours, days or even months a person may be normal but then an attack may suddenly happen out of nowhere.
Most of you may not think of asthma as a killer disease, yet more that 5,000 Americans die of asthma each year. According to the Mayo Clinic web page, asthma also accounts for more that 400,000 hospital discharges annually. As the number of people with asthma increases, the more likely you are to come in contact with a person who has the disease. As far as I can remember, I have had asthma my whole life. My mother and one of my sisters also have asthma, so I have a first hand experience with it. This morning, I will discuss some interesting facts about asthma, I will specifically focus on what it is, warning signs, symptoms, causes, and the treatments that are used.
Even though there is no cure for asthma, there are two main types of medication used for the treatment of it. The first is long term medication that aids in decreasing the inflammation of a person’s airways and also serves as a preventative measure for symptoms and asthma attacks. These medicines are usually anti-inflammatory drugs that are taken daily to reduce future symptoms, but do not act as a quick fix...
Nursing Diagnosis I for Patient R.M. is ineffective airway clearance related to retained secretions. This is evidenced by a weak unproductive cough and by both objective and subjective data. Objective data includes diagnosis of pneumonia, functional decline, and dyspnea. Subjective data include the patient’s complaints of feeling short of breath, even with assistance with basic ADLs. This is a crucial nursing diagnosis as pneumonia is a serious condition that is the eighth leading cause of death in the United States and the number one cause of death from infectious diseases (Lemon, & Burke, 2011). It is vital to keep the airway clear of the mucus that may be produced from the inflammatory response of pneumonia. This care plan is increasingly important because of R.M.'s state of functional decline; he is unable to perform ADL and to elicit a strong cough by himself due to his slouched posture. Respiratory infections and in this case, pneumonia, will further impair the airway (Lemon, & Burke, 2011). Because of the combination of pneumonia and R.M's other diagnoses of lifelong asthma, it is imperative that the nursing care plan of ineffective airway clearance be carried out. The first goal of this care plan was to have the patient breathe deeply and cough to remove secretions. It is important that the nurse help the patient deep breathe in an upright position; this is the best position for chest expansion, which promotes expansion and ventilation of all lung fields (Sparks and Taylor, 2011). It is also important the nurse teach the patient an easily performed cough technique and help mobilize the patient with ADL's. This helps the patient learn to cough and clear their airways without fatigue (Sparks a...